{
    "info": {
        "nct_id": "NCT00474760",
        "official_title": "Phase 1, Open Label, Multiple Dose Escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of CP 751,871 In Patients With Advanced Solid Tumors",
        "inclusion_criteria": "* Diagnosis of Ewing's sarcoma family tumors\nHealthy volunteers allowed\nMust have minimum age of 9 Years",
        "exclusion_criteria": "* Concurrent treatment with any other anti tumor agents",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Diagnosis of Ewing's sarcoma family tumors",
            "criterions": [
                {
                    "exact_snippets": "Diagnosis of Ewing's sarcoma family tumors",
                    "criterion": "Ewing's sarcoma family tumors",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "volunteer health status",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "healthy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 9 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 9 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 9,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Concurrent treatment with any other anti tumor agents",
            "criterions": [
                {
                    "exact_snippets": "Concurrent treatment with any other anti tumor agents",
                    "criterion": "concurrent treatment with anti tumor agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}